Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of macitentan 10 mg tablets in healthy Thai volunteers
TCTR20231103004Phase 1Not yet recruiting
- Sponsor
- Unison Laboratories
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of macitentan (2 arms), sponsored by Unison Laboratories. Primary endpoints: Cmax, AUC0-t and 2 more. Planned start May 2025; status: not yet recruiting.
02
Drugs
macitentan
Beyond the preview
Go deeper on TCTR20231103004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20231103004.